MPR Weekly Dose Podcast #130

This week, the FDA’s vote on AMX0035, the potential ALS treatment; CPAP and BiPAP device recalls; Orphan Drug designation for a novel CRISPR therapy; Imfinzi gains new approval; and Spevigo is approved for pustular psoriasis flares.